Suppression of heat-induced p53 accumulation and activation by CDDP or X-rays in human glioblastoma cells

International Journal of Oncology

Volumn 13, Issue 4, 1998, Pages 741-747

  Matsumoto, Hideki ^a   Hayashi, Sachiko ^a   Shioura, Hiroki ^a   Ohtsubo, Toshio ^a   Nishida, Tsuneo ^b   Kitai, Ryuhei ^a   Ohnishi, Takeo ^c   Kano, Eiichi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b FUKUI UNIVERSITY OF TECHNOLOGY   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

CDDP; Chemosensitivity; Hyperthermia; P53; Radiosensitivity; Thermosensitivity; X rays

Indexed keywords

CISPLATIN; PROTEIN P53;

ARTICLE; CELL CYCLE G1 PHASE; CHEMOSENSITIVITY; DNA BINDING; DNA DAMAGE; GLIOBLASTOMA; GROWTH INHIBITION; HEAT TOLERANCE; HUMAN; HUMAN CELL; HYPERTHERMIA; IONIZING RADIATION; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR GROWTH;

EID: 0031687586     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.4.741     Document Type: Article

References (46)

1. Murray A: Cell cycle checkpoint. Curr Opin Cell Biol 6: 872-876, 1994.
2. McIlwrath AJ, Vasey PA, Ross GM and Brown R: Cell cycle arrest and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 54: 3718-3722, 1994.
3. O'Connor PK, Jackman J, Jondle J, Bhatia K, Magrath I and Kohn KW: Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res 53: 4776-4780, 1993.
4. Kastan MB, Zhan QS, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ: A mammalian cell cycle checkpoint utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell 71: 587-597, 1992.
5. Barak Y, Juven T, Haffner R and Oren M: MDM2 expression is induced by wild-type p53 activity. EMBO J 12: 461-468, 1993.
6. Weintraub H, Hauschka S and Tapscott SJ: The MCK enhancer contains ap53 responsive element. Proc Natl Acad Sci USA 88: 4570-4574, 1991.
7. Matsumoto H, Wang X, Takahashi A and Ohnishi T: Induction of cdk2 after γ-ray irradiation is dependent on p53 status. Int J Oncol 10: 1257-1260, 1997.
8. Prives C and Manfredi JJ: The p53 tumor suppressor protein: meeting review. Genes Dev 7: 529-534, 1993.
9. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent J, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
10. Gu Y, Turck CW and Morgan DO: Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710, 1993.
11. 1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
12. Bristow RG, Kang A, Peacock J, Chung S, Benchimol S and Hill RP: Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. Oncogene 9: 1527-1536, 1994.
13. Lee J and Bernstein A: p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 90: 5742-5746, 1993.
14. Pardo FS, Su M, Borek C, Preffer F, Dombkowski D, Gerweck L and Schmidt EV: Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance. Radiat Res 140: 180-185, 1994.
15. 1 checkpoint is retained in tumorigenic rat embryo fibroblast clones transformed by the human papillomavirus type 16 E7 gene and EJ-ras. Mol Cell Biol 15: 1446-1454, 1995.
16. Biard DSF, Martin M, Rhun YL, Duthu A, Lefaix JL, May E and May P: Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Res 54: 3361-3364, 1994.
17. Fan S, Smith ML, Rivet II DJ, Duba D, Zhan Q, Kohn KW and Fornace AJ Jr: Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 55: 1649-1654, 1995.
18. Brachman DG, Beckett M, Graves D, Harat D, Vokes E and Weichselbaum RR: p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 53: 3667-3669, 1993.
19. 1 checkpoint does not decrease cell survival following DNA damage. Cancer Res 53: 4164-4168, 1993.
20. 1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 14: 6264-6277, 1994.
21. Matsumoto H, Shimura M, Omatsu T, Okaichi K, Majima H and Ohnishi T: p53 proteins accumulated by heat stress associate with heat shock proteins HSP72/HSC73 in human glioblastoma cell lines. Cancer Lett 87: 39-46, 1994.
22. Matsumoto H, Takahashi A, Wang X, Ohnishi K and Ohnishi T: Transfection of p55-knockout mouse fibroblasts with wild-type p53 increases the thermosensitivity and stimulates apoptosis induced by heat stress. Int J Radiat Oncol Biol Phys 38: 1089-1095, 1997.
23. Dewey WC: Interaction of heat with radiation and chemotherapy. Cancer Res 44 (Suppl.): 4714s-4720s, 1984.
24. Holahan EV, Highfield DP, Holahan PK and Dewey WC: Hyperthermic killing and hyperthermic radiosensitization in Chinese hamster ovary cells: effects of pH and thermal tolerance. Radiat Res 97: 108-131, 1984.
25. Miyahara T, Ueda K, Akaboshi M, Shimada Y, Imamura M and Utsumi H: Hyperthermic enhancement of cytotoxicity and increased uptake of cis-diamminedichloroplatinum(II) in cultured human esophageal cancer cells. Jpn J Cancer Res 84: 336-340, 1993.
26. Ohno S, Siddik ZH, Kido Y, Zwelling LA and Bull JM: Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells. Cancer Chemother Pharmacol 34: 302-306, 1994.
27. Ohtsubo T, Chang SW, Tsuji K, Picha P, Saito H and Kano E: Effects of cis-diamminedichloroplatinum (CDDP) and cisdiammine(1,1-cyclobutanedicarboxylate) platinum (CBDCA) on thermotolerance development and thermosensitivity of the thermotolerant cells. Int J Hyperthermia 6: 1031-1039, 1990.
28. Raaphorst GP, Feeley MM, Chu GL and Dewey WC: A comparison of the enhancement of radiation sensitivity and DNA polymerase inactivation by hyperthermia in human glioma cells. Radiat Res 134: 331-336, 1993.
29. Urano M, Kahn J, Majima H and Gerweck LE: The cytotoxic effect of cis-diamminedichloroplatinum(II) on cultured Chinese hamster ovary cells at elevated temperature: Arrhenius plot analysis. Int J Hyperthermia 6: 581-590, 1990.
30. Yano T, Nakatani K, Nakano H, Ihara M and Ohnishi T: Hyperthermic enhancement of cis-diamminedichloroplatinum(II)-induced DNA damage in human esophageal cancer transplantable to nude mice. Anticancer Res 13: 1989-1997, 1993.
31. Yano T, Nakatani K, Watanabe A, Nakano H and Ohnishi T: Effects of pre-heating on cis-diamminedichloroplatinum(II)-hyperthermia-induced tumour growth depression of transplantable human oesophageal cancer to nude mice. Int J Hyperthermia 9: 699-708, 1993.
32. Dikomey E: Effect of hyperthermia at 42 and 45 degrees C on repair of radiation-induced DNA strand breaks in CHO cells. Int J Radiat Biol Relat Stud Phys Chem Med 41: 603-614, 1982.
33. Raaphorst GP, Yang DP and Ng CE: Effect of protracted mild hyperthermia on polymerase activity in a human melanoma cell line. Int J Hyperthermia 10: 827-834, 1990.
34. Walters RL and Axtell J: Repair of DNA strand breaks at hyperthermic temperatures in Chinese hamster ovary cells. Int J Radiat Biol 61: 43-48, 1992.
35. Ohnishi T, Wang X, Ohnishi K, Matsumoto H and Takahashi A: p53-dependent induction of WAF1 by heat treatment in human glioblastoma cells. J Biol Chem 271: 14510-14513, 1996.
36. Ohtsubo T, Wang X, Takahashi A, Ohnishi K, Saito H, Song CW and Ohnishi T: p53-dependent induction of WAF1 by a low-pH culture condition in human glioblastoma cells. Cancer Res 57: 3910-3913, 1997.
37. Matsumoto H, Hayashi S, Shioura H, Ohtsubo T, Ohnishi T and Kano E: Suppression of heat-induced hsp72 accumulation by cisplatin in human glioblastoma cells. Cancer Lett 110: 253-257, 1996.
38. Matsumoto H, Hayashi S, Shioura H, Ohtsubo T, Kitai R, Ohnishi K, Hayashi N, Ohnishi T and Kano E: Suppression of heat-induced HSF activation by CDDP in human glioblastoma cells. Int J Radiat Oncol Biol Phys 41: 915-920, 1998.
39. El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW and Vogelstein B: Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55: 2910-2919, 1995.
40. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849, 1993.
41. Hall PA, Meek D and Lane DP: p53-integrating the complexity. J Pathol 180: 1-5, 1996.
42. Eichholtz-Wirth H and Hietel B: Heat sensitization to cisplatin in two cell lines with different drug sensitivities. Int J Hypcrthermia 6: 47-55, 1990.
43. Eliopoulos AG, Kerr DJ, Herod J, Hodgkins L, Krajewski S, Reed JC and Young LS: The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. Oncogene 11: 1217-1228, 1995.
44. Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC and Zunino FA: Association between cisplatin resistance and mutation of p53 gene and reduced Bax expression in ovarian carcinoma cell systems. Cancer Res 56: 556-562, 1996.
45. Rusch V, Klimstra D, Venkatraman E, Oliver J, Martini N, Gralla R, Kris M and Dmitrovski E: Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer. Cancer Res 55: 5038-5042, 1995.
46. De Fromentel CC and Soussi T: TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer 4: 1-15, 1992.